Cromwell Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$287K Buy
742
+200
+37% +$74.2K 0.13% 143
2026
Q1
$159K Sell
542
-207
-28% -$68K 0.09% 226
2025
Q4
$263K Sell
749
-1
-0.1% -$338 0.14% 135
2025
Q3
$242K Sell
750
-12
-2% -$3.73K 0.13% 144
2025
Q2
$296K Buy
762
+135
+22% +$54.3K 0.18% 115
2025
Q1
$273K Sell
627
-97
-13% -$38.9K 0.18% 116
2024
Q4
$267K Buy
724
+4
+0.6% +$1.67K 0.15% 115
2024
Q3
$374K Buy
720
+47
+7% +$25.1K 0.24% 83
2024
Q2
$365K Buy
+673
New +$356K 0.22% 86

Other funds holding ELV

Cromwell Holdings's ELV Position: Q2 2026 in Review

Cromwell Holdings increased its Elevance Health (ELV) stake by 37% in Q2 2026, buying an estimated $74.2K and bringing the position to 742 shares worth $287K. The position accounts for 0.13% of the portfolio, ranked #143.

Cromwell Holdings first reported a position in ELV in Q2 2024 and has held it in 9 quarters since. The position peaked at $374K in Q3 2024. 368 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Cromwell Holdings held 742 shares of Elevance Health worth $287K as of Q2 2026.
  • Cromwell Holdings bought 200 Elevance Health shares in Q2 2026, an estimated $74.2K.
  • Elevance Health made up 0.13% of Cromwell Holdings's portfolio in Q2 2026, its #143 holding.
  • Cromwell Holdings first reported a position in Elevance Health in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's Elevance Health position peaked at $374K in Q3 2024.
  • 368 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.